HEY YOU!
AGGIE GRADUATE STUDENTS
Get Ready
SPRING FLING IS RIGHT AROUND THE CORNER
It’s a Celebration for Graduate Students,
Friends and Families
March 26, 1994
On campus at the Grove (Shine) or DeWare (Rain)
From 12:00 (noon) to 5:00 p.m.
Sponsored by Graduate Student Council
ALLIED HEALTH
PROFESSIONALS
Discover a challenging
future with opportunities to
advance. Serve your country
while you serve your career with:
• great pay and benefits
• normal working hours
• complete medical and dental
care
• 30 days vacation with pay per
year
Find out how to qualify as an Air
Force professional. Call
USAF HEALTH PROFESSIONS
TOLL FREE
1-800-423-USAF
r
cc
o
US
citizens with a 3.0
GPR are eligible
Informational
MEETINGS
Wed. March 2, 10:15am
fhur. March 10, 4:00pm
251 Bizzell flail West
Study Abroad Programs, 161 Bizzell Hall West, 845-0544
ITESM
Oportunidades
de trabajo en Mexico
Institute Tecnologico
y de Estudios Superiores
de Monterrey
Institucion: Sistema ITESM
Puesto: Profesor-consultor-investigador en cualquiera de los 26
campus del Sistema ITESM
Perfil: • Grado de Maestria o Doctorado
• Disponibilidad para agosto de 1994
• Espafiol indispensable
Areas: Administracion, Comercio Internacional, Computacion,
Contabilidad, Finanzas, Economia, Educacion, Estadistica,
Idiomas, Lingiiistica, Ingenieria Industrial, Matematicas,
Mercadotecnia, Ingenieria de Sistemas y Sistemas de Informacion
Lugar: 510 RUDDER TOWER
Texas A&M University
Dia: Jueves 24 de Marzo
Mora: 6:15 p.m.
Para mayor informacion comunicarse con Felipe Zambrano - 764-7534
SiaFTorci Qpgra I>Qusg Presents
JIMMIE DAEE
GILMORE
Voted ' ’ of the
year, and best folk act
in 1994 by the Austin
Music Awards; voted
country artist of the
year in both 1992 and
1993 by Rolling Stone
magazine.
LIVE IN-STORE PERFORMANCE
Thursday March 24 - 5:00pm
Marooned Records
1 1 O College Main 846-001 7
Page 14
The Battalion
Thursday, March 24,19
Tubularmcm
By Boomer Cardinale
Trading cards Tb
help police
improve relation
with city youth
The Associated Press
MICH/
s BELINt
HEATH
TONI <
Bartholomew
by lialvin
Eisenhower
By Alex
FORT WORTH — In a city pup
by skyrocketing violence belweti
youth gangs, authorities are tin
hard to improve their relations!];
with kids.
One of the newest proposal is;!
create "police trading cards.”
Police say they hope the cards« !
elevate police to "hero status" in it
minds of youths — particularly];
neighborhoods now troubled I
guns, drugs and gangs.
"I wouldn’t say we’re looking!
the trading cards primarily beejus*
of the gang problem in Fort Wortk
We’ve been debating it for seven
years, even before the gang situatio:
was as pronounced as it is now.Iiiii
timely though,” Lt. Greg Bradlt
said Wednesday.
"And actually, we hope the card
will be helpful for the kids who aren;
involved in crime as well as fortb
who are, and maybe remove the barn
ers that may be there between som
kids and officers."
Bradley and Chief Thomas Wind
ham took the idea to the City Count
on Tuesday.
"It’s not a done deal. We wamcj
to make sure we had the councili
blessing to proceed further, and:
don’t think we got a yes ornoom:
yet. We’re waiting to embark onii,
but I expect we’ll get the go-ahead,
Bradley said.
Dr.
. . , r , ■dream.
I ne idea ol police trading cards thinkii
isn’t new. Other cities in the Dallas-
Fort Worth area — including Arling Bhe co
ton, Cleburne, DeSoto. Mesquite anc jtuden
University Park — have tried thecatis jormit
as a means to link kids with officers
Violence
Continued from Page 1
timony before a commission investi
gating the mosque massacre, Barak
said the Palestinian bystander appar
ently died from gunfire by the guerril
las. Al-Ahli hospital in Hebron said an
army bullet killed Hunduq Zahdeh,
34, who was five months' pregnant.
The military had no immediate re
sponse to a statement by Mohtasseb
Children’s Hospital condemning sol
diers for firing from the roof and
tromping repeatedly through wards
holding 32 children despite their ob
vious fright.
"The shooting continued all night.
The children were very scared and
cried all night. They could not sleep,"
said the hospital’s director, Dr.
Hisham Abu Gharbiyah.
At a Jerusalem news conference,
af the
:ation
yard r
PLO negotiator Saeb Erekat sharpkBthat 1
criticized Prime Minister Yitzhak Ri decadt
bin. ffithe eff
"Rabin talks a lot about peace i.'i hous
English, but his orders in Hebrew ti! ^ tui
his troops is to continue their terro: tl0n 1
campaign and massacres against civil ' <)VC ’ 1
ians," he said. .
mrenc
thems
and c
DepoProvera
occur and, therefore, the bleeding that comes with your normal menstruation does not take
place. When you stop using DEPO-PROVERA your menstrual period will usually, in time,
return to its normal cycle.
Contraceptive Injection
(sterile medroxyprogesterone acetate suspension, USP)
2. Bone Mineral Changes
Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral
stored in your bones. This could increase your risk of developing bone fractures. The rate
of bone mineral loss is greatest in the early years of DEPO-PROVERA use, but after that, it
begins to resemble the normal rate of age-related bone mineral loss.
WHAT IS DEPO-PROVERA CONTRACEPTIVE INJECTION?
DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an i
muscular Injection (a shot) in the buttock or upper arm once every 3 months. To con
intra-
, . . . - . - continue
our contraceptive protection, you must return for your next injection promptly at the end of
o months. DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to
(but not the same as) the natural hormone progesterone, which is produced by your ovaries
during the second half of your menstrual cycle., DEPO-PROVERA acts by preventing your
egg cells from ripening. If an egg is not released from the ovaries during your menstrual
cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA also
causes changes in the lining of your uterus that make it less likely for pregnancy to occur.
3. Cancer
Studies of women who have used different forms of contraception found that women who
used DEPO-PROVERA for contraception had no Increased overall risk of developing cancer
of the breast, ovary, uterus, cervix, or liver. However, women under 35 years of age whose
first exposure to DEPO-PROVERA was within the previous 4 years may have a slightly
increased risk of developing breast cancer similar to that seen with oral contraceptives.
You should discuss this with your health-care provider.
4. Accidental Pregnancy
HOW EFFECTIVE IS DEPO-PROVERA CONTRACEPTIVE INJECTION?
DEPO-PROVERA is over 99% effective, making it one of the most reliable methods of birth
control available. This means that the average annual pregnancy rate is less than one for
icy
Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental
pregnancy for women who get their shots regularly (every 3 months) is very low. While there
have been reports of an increased risk of low birth weight and neonatal infant death or
other health problems in infants conceived close to the time of injection, such pregnancies
are rare. If you think you may have become pregnant while using DEPO-PROVERA for con-
>wn.
Ito be
they f
segre,
will b
to CO]
outsid
Stui
expose
pie an-
reason
rural n
0
traception, see your health-care provider as soon as possible.
control available, i nis means that the average annual pregnancy rate is less than one for
every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive
methods depends in part on how reliably each woman uses the method. The effectiveness
of DEPO-PROVERA depends only on the patient returning every 3 months for her next
injection. Your health-care provider will help you compare DEPO-PROVERA with other con
traceptive methods and give you the information you need in order to decide which contra
ceptive method is the right choice for you.
5. Other Risks
Women who use hormone-based contraceptives may have an increased risk of blood clots
or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg
will begin to develop outside of the uterus (ectopic pregnancy). While these events are rare,
you should tell your health-care provider if you have any of the problems listed in the next
section.
JOSI
ELCI
The following table shows the percent of women who got pregnant while using different
kinds of contraceptive methods. It gives both the lowest expected rate of pregancy (the
rate expected in women who use each method exactly as it should be used) and the typical
rate of pregnancy (which includes women who became pregnant because they forgot to
use their birth control or because they did not follow the directions exactly).
WHAT SYMPTOMS MAY SIGNAL PROBLEMS WHILE USING DEPO-PROVERA
CONTRACEPTIVE INJECTION?
PERCENT OF WOMEN EXPERIENCING AN ACCIDENTAL PREGNANCY
IN THE FIRST YEAR OF CONTINUOUS USE
Call your health-care provider immediately if any of these problems occur following an
injection of DEPO-PROVERA: Sharp chest pain, coughing of blood, or sudden shortness ot
breath (indicating a possible clot in the lung); sudden severe headache or vomiting, dizzi
ness or fainting, problems with your eyesight or speech, weakness, or numbness in an arm
or leg (indicating a possible stroke); severe pain or swelling in the calf (indicating a possible
clot in the leg); unusually heavy vaginal bleeding; severe pain or tenderness In the lower
abdominal area; or persistent pain, pus, or bleeding at the injection site.
Method
Lowest
Expected
Typical
DEPO-PROVERA
0.3
0.3
Implants (Norplant*)
0.3
0.3
Female sterilization
0.2
0.4
Male sterilization
0.1
0.15
Oral contraceptive (pill)
_
3
Combined
0.1
Progestogen only
0.5
-
IUD
3
Proqestasert
2.0
Copper T 380A
0.8
-
Condom (without spermicide)
2
12
Diaphragm (with spermicide)
6
18
Cervical Cap
6
18
Withdrawal
4
18
Periodic abstinence
1 -9
20
Spermicide alone
3
21
Vaginal Sponge
Used before childbirth
6
18
Used after childbirth
9
28
No method
85
85
Source: Trussell et at; Obstet Gyncol 76:558,1990
WHAT ARE THE POSSIBLE SIDE EFFECTS OF DEPO-PROVERA
CONTRACEPTIVE INJECTION?
1. Weight Gain
You may experience a weight gain while you are using DEPO-PROVERA. About two thirds
of the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5
pounds during the first year of use. You may continue to gain weight after the first year.
Women in one large study who used DEPO-PROVERA for 2 years gained an average total
of 8.1 pounds over those 2 years, or approximately 4 pounds per year. Women who contin
ued for 4 years gained an average total of 13.8 pounds over those 4 years, or approximate
ly 3.5 pounds per year. Women who continued for 6 years gained an average total of 16.5
pounds over those 6 years, or approximately 2.75 pounds per year.
2. Other Side Effects
In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects that may or may not have been related to their use of
DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness,
abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps,
nausea, vaginal discharge or irritation, breast swelling and tenderness, bloating, swelling of
the hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair growth or
excessive hair loss, rash, and hot flashes. Other problems were reported by very few ot the
women in the clinical trials, but some of these could be serious. These include convulsions,
jaundice, urinary tract infections, allergic reactions, fainting, paralysis, osteoporosis, lack ot
return to fertility, deep vein thrombosis, pulmonary embolus, breast cancer, or cervical can
cer. If these or any other problems occur during your use of DEPO-PROVERA, discuss
' alth-c
Cues
credit c;
north-e,
feel the
energizt
Was'
come uj
place w
dodginj
made hi
dealers ’
spraying
them with your health-care provider.
SHOULD ANY PRECAUTIONS BE FOLLOWED DURING USE OF DEPO-PROVERA
CONTRACEPTIVE INJECTION?
WHO SHOULD NOT USE DEPO-PROVERA CONTRACEPTIVE INJECTION?
1. Missed Periods
Not all women should use DEPO-PROVERA. You should not use DEPO-PROVERA if you
think you might be pregnant, have any vaginal bleeding without a known reason, have
had cancer of the breast, have had a stroke, have or have had blood clots (phlebitis) in
your legs, have problems with your liver or liver disease, or are allergic to DEPO-
PROVERA (medroxyprogesterone acetate or any of its other ingredients). You will have a
physical examination before your doctor prescribes DEPO-PROVERA. It is important to
tell your doctor if you are taking any prescription or over-the-counter medications or if
During the time you are using DEPO-PROVERA for contraception, you may skip a pei
or your periods may stop completely. If you have been receiving your DEPO-PROVI
iriod,
VERA
injections regularly every 3 months, then you are probably not pregnant. However, If you
think that you may be pregnant, see your health-care provider,
you have a family history of breast cancer; an abnormal mammogram (breast x-ray),
fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples; kidney
disease; irregular or scanty menstrual periods; high blood pressure; migraine headaches;
asthma; epilepsy (convulsions or seizures); diabetes or a family history of diabetes; or a
history of depression.
2. Laboratory Test Interactions
If you are scheduled for any laboratory tests, tell your health-care provider that you are
using DEPO-PROVERA for contraception. Certain blood tests are affected by hormones
such as DEPO-PROVERA.
3. Drug interactions
Cytadren (aminoglutethimide) is an anticancer drug that may significantly decrease the
effectiveness of DEPO-PROVERA if the two drugs are given during the same time.
WHAT IF I WANT TO BECOME PREGNANT AFTER USING DEPO-PROVERA
CONTRACEPTIVE INJECTION?
Because DEPO-PROVERA is a long-acting birth control method, it takes some time after
your last injection for its effect to wear off. Based on the results from a large study done in
the United States, for women who stop using DEPO-PROVERA in order to become preg
nant, it is expected that about half of those who become pregnant will do so in about 10
months after their last injection; about two thirds of those who become pregnant will do so
in about 12 months; about 83% of those who become pregnant will do so in about 15
months; and about 93% of those who become pregnant will do so in about 18 months after
their last injection. The length of time you use DEPO-PROVERA has no effect on how long
it takes you to become pregnant after you stop using it.
4. Nursing Mothers
Although DEPO-PROVERA can be passed to the nursing infant in the breast milk, no harm
ful effects have been found in these children. DEPO-PROVERA does not prevent the
breasts from producing milk, so it can be used by nursing mothers. However, to minimize
the amount of DEPO-PROVERA that is passed to the infant in the first weeks after birth
you should wait until 6 weeks after childbirth before you start using DEPO-PROVERA for
contraception.
WHAT ARE THE RISKS OF USING DEPO-PROVERA
CONTRACEPTIVE INJECTION?
1. Irregular Menstrual Bleeding
The side effect reported most frequently by women who use DEPO-PROVERA for contra
ception is a change in their normal menstrual cycle. During the first year of using DEPO-
PROVERA, you might have one or more of the following changes: Irregular or unpredictable
bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding at ail
Unusually heavy or continuous bleeding, however, is not a usual effect of DEPO-PROVERA
—> =* *V| IS * -*-—*-* - ■ ■ •
HOW OFTEN DO I GET MY SHOT OF DEPO-PROVERA CONTRACEPTIVE INJECTION?
The recommended dose of DEPO-PROVERA is 150 mg every 3 months given in a single
intramuscular injection in the buttock or upper arm. To make sure that you are not pregnant
at the time of the first injection, it is important that the injection be given only during the first
5 days after the beginning of a normal menstrual period. If used following the delivery of a
child, the first injection of DEPO-PROVERA should be given within 5 days after childbirth if
you are not breast-feeding or 6 weeks after childbirth if you are breast-feeding. If you wait
longer than 3 months between injections, or longer than 6 weeks after childbirth, your
health-care provider should determine that you are not pregnant before giving you your
injection of DEPO-PROVERA.
and if this ha|
use of DEPO-PROVI
ods completely. In clinic
ed no menstrual bleedim
reported no menstrual bleeding after
With continued
having peri-
studied report-
after 1 year of use, and 68% of the women studied
_____ ___,_ years of use. The reason that your periods stop is
because DEPO-PROVERA causes a resting state in your ovaries. When your ovaries do not
release an egg monthly, the regular monthly growth of the lining of your uterus does not
Caution: Federal law prohibits dispensing without a prescription. You must see a doctor to
receive a prescription.
Asa
■eel ob]
jyfatt M
rations
whetha
‘Qterpn
Uowevf
Utd wc,
ate it,
ane’s o
he p u b
^oup,
Popular
We ]
‘Vhich
•vith be
Upjohn
The Upjohn Company
Kalamazoo, Ml 49001, USA
CB-2-S USJ 9529.00